Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Stomach Neoplasms × Everolimus × Clear all

Phase

Phase 2 3 Phase 1/2 3 Phase 3 2 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 18 Carcinoma, Renal Cell 16 Neoplasm Metastasis 13 Carcinoma, Non-Small-Cell Lung 13 Neoplasms 11 Neuroendocrine Tumors 8 Recurrence 7 Lung Neoplasms 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Prostatic Neoplasms 5 Multiple Myeloma 5 Leukemia, Myeloid, Acute 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Kidney Neoplasms 5 Brain Neoplasms 5 Triple Negative Breast Neoplasms 4 Lymphoma, Non-Hodgkin 4 Lymphoma, Mantle-Cell 4 Lymphoma, Large B-Cell, Diffuse 4 Hodgkin Disease 4 Head and Neck Neoplasms 4 Glioblastoma 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Small Cell Lung Carcinoma 3 Pancreatic Neoplasms 3 Lymphoma, Follicular 3 Lymphoma 3 Glioma 3 Colorectal Neoplasms 3 Carcinoma, Hepatocellular 3

Interventions

Cisplatin 24 pembrolizumab 23 Oxaliplatin 22 Fluorouracil 22 Irinotecan 21 Capecitabine 19 Leucovorin 17 Paclitaxel 16 Cyclophosphamide 14 Trastuzumab 11 Carboplatin 11 Nivolumab 10 Docetaxel 9 Bevacizumab 9 fludarabine 8 S 1 (combination) 8 Gemcitabine 8 aldesleukin 7 Ramucirumab 7 atezolizumab 6 130-nm albumin-bound paclitaxel 6 Taxes 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Biopsy 5 veliparib 4 tislelizumab 4 dehydroftorafur 4 Sunitinib 4 Specimen Handling 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01042782 2012-08-03

S387

Krankenhaus Nordwest

Phase 1 Completed

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡